| Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient (NCT01436669) | Philips Healthcare | 2011-06-01 |
| Early Smoking Reduction or Cessation by Means of no Nicotine Electronic Cigarette Added to Standard Counselling. (NCT01733706) | European Institute of Oncology | 2011-06-01 |
| Enhancing Coping Skills in Patients With Cancer (NCT01359072) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-06-01 |
| GSK1120212 Food-effect Study (NCT01371487) | GlaxoSmithKline | 2011-05-02 |
| Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal Study (NCT01506869) | Shanghai Jiao Tong University School of Medicine | 2011-05-01 |
| A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients (NCT01313780) | Mundipharma Korea Ltd | 2011-05-01 |
| A Rollover Study for Patients Who Participated in Other Romidepsin Protocols (NCT01353664) | Celgene | 2011-05-01 |
| Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France (NCT01531478) | Centre Hospitalier Universitaire de Saint Etienne | 2011-05-01 |
| Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry (NCT01843140) | University of California, San Diego | 2011-05-01 |
| Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer (NCT01111032) | Hamilton Health Sciences Corporation | 2011-05-01 |
| E-health Intervention for Cancer Survivors 2.0 (NCT01348997) | Northwestern University | 2011-05-01 |
| Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias (NCT00920140) | GlaxoSmithKline | 2011-05-01 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| Multiple Ascending Dose of BMS-911543 (NCT01236352) | Bristol-Myers Squibb | 2011-04-07 |
| AMG 319 Lymphoid Malignancy FIH (NCT01300026) | Amgen | 2011-04-01 |
| Polymorphisms in the Vitamin D System and Health (NCT01395303) | University of Tromso | 2011-04-01 |
| RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (NCT01809106) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| The Mental Health and Dynamic Referral for Oncology Protocol (MHADRO) (NCT01442285) | University of Massachusetts, Worcester | 2011-04-01 |
| Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer (NCT01396733) | Asan Medical Center | 2011-04-01 |
| A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies (NCT01325441) | Sumitomo Pharma America, Inc. | 2011-04-01 |
| To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib (NCT01548170) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2011-04-01 |
| VOICE: Values and Options in Cancer Care (NCT01485627) | University of Rochester | 2011-04-01 |
| Gulf Long-Term Follow-Up Study (NCT01287000) | National Institute of Environmental Health Sciences (NIEHS) | 2011-03-24 |
| Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors (NCT01292655) | Bristol-Myers Squibb | 2011-03-03 |
| Tapentadol in Chronic Malignant Tumour Related Pain (NCT01264887) | Grünenthal GmbH | 2011-03-01 |
| MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies (NCT01235897) | University of California, San Francisco | 2011-03-01 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer (NCT01352884) | MedImmune LLC | 2011-03-01 |
| Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial (NCT02035098) | Azienda USL Reggio Emilia - IRCCS | 2011-03-01 |
| Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212 (NCT01387204) | GlaxoSmithKline | 2011-02-15 |
| Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors (NCT01231932) | National Institute of Nursing Research (NINR) | 2011-02-04 |
| Social Work Intervention Focused on Transitions (NCT02232126) | University of Southern California | 2011-02-01 |
| Adult and Paediatric Patient Radiation Doses From Multidetector Row Computed Tomography Scans: a National Survey (NCT01436006) | University of Palermo | 2011-02-01 |
| Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer (NCT01553656) | Exelixis | 2011-02-01 |
| Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery (NCT01278537) | Charite University, Berlin, Germany | 2011-02-01 |
| An Observational Post-Marketing Safety Registry of Sativex® (NCT02073474) | Jazz Pharmaceuticals | 2011-02-01 |
| Procalcitonin as a Marker of Infection in Cancer Patients (NCT01227109) | Herlev Hospital | 2011-02-01 |
| A Study of E7080 in Subjects With Solid Tumor (NCT01268293) | Eisai Co., Ltd. | 2011-02-01 |
| Existential Issues in Elderly People With Cancer (NCT01309815) | Sykehuset Innlandet HF | 2011-02-01 |
| Virtual Reality Intervention in Cancer Genetics (NCT01310829) | M.D. Anderson Cancer Center | 2011-02-01 |
| An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01262963) | GlaxoSmithKline | 2011-01-26 |
| Ovarian Tissue Cryopreservation for Fertility Preservation (NCT05875155) | University of Pittsburgh | 2011-01-13 |
| Assessing the Efficacy of a Psychosocial Intervention Program for Siblings of Children With Cancer (NCT02787330) | The Hospital for Sick Children | 2011-01-01 |
| Rechallenge of BRAF +/- MEK Inhibitors Following an Adverse Event in Patients With Cancer (NCT05080361) | University Hospital, Caen | 2011-01-01 |
| Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer (NCT01248611) | St. Olavs Hospital | 2011-01-01 |
| Ovarian Reserve Testing in Female Young Adult Cancer Survivors (NCT01421095) | University of California, San Diego | 2011-01-01 |
| Obesity: Cancer Risk Among African Americans (NCT01294657) | M.D. Anderson Cancer Center | 2011-01-01 |
| Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock (NCT01304680) | Grupo de Apoio ao Adolescente e a Crianca com Cancer | 2011-01-01 |
| Immediate-Release Oxycodone Capsules Study in Cancer Pain (NCT01675622) | Mundipharma (China) Pharmaceutical Co. Ltd | 2011-01-01 |
| The eCALM Study - An Online Mindfulness-Based Stress Reduction Program for Individuals Living With Cancer in Alberta (NCT01476891) | Alberta Health services | 2011-01-01 |
| Cancer Survivorship Issues: A Survey of Patients in India.AIIMS Study (CANSURVIVE) (NCT01304199) | All India Institute of Medical Sciences | 2011-01-01 |
| Cancer Prevention and Care Among Aged (NCT01831375) | Case Western Reserve University | 2011-01-01 |
| A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer (NCT01300533) | BIND Therapeutics | 2011-01-01 |
| Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment (NCT01201018) | Oshadi Drug Administration | 2011-01-01 |
| Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures (NCT01287013) | National Institutes of Health Clinical Center (CC) | 2011-01-01 |
| Outlook Quality of Life Intervention Study (NCT01044290) | VA Office of Research and Development | 2011-01-01 |
| A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma (NCT01227889) | GlaxoSmithKline | 2010-12-23 |
| Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage (NCT01293851) | National Institute of Nursing Research (NINR) | 2010-12-22 |
| A Study of AMG 337 in Subjects With Advanced Solid Tumors (NCT01253707) | Amgen | 2010-12-08 |
| Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors. (NCT01248858) | GlaxoSmithKline | 2010-12-03 |
| A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients (NCT01262235) | Arbutus Biopharma Corporation | 2010-12-01 |
| Physician Liver Function Test (LFT) Monitoring for Tykerb Pts (NCT01462552) | GlaxoSmithKline | 2010-12-01 |
| Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer (NCT01295463) | Institut Català d'Oncologia | 2010-12-01 |
| Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity (NCT01421758) | University of North Carolina, Chapel Hill | 2010-12-01 |
| F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases (NCT01254929) | Seattle Nuclear Medicine | 2010-12-01 |
| Evaluation of TK3 in Improving Quality of Life in Patients With Malignancy Under Chemotherapy (NCT01168206) | Lavilabor Natural Products Ltd | 2010-12-01 |
| An Evaluation of the Usability and Usefulness of a Multi-language Online Patient Education Module (NCT01248676) | Sunnybrook Health Sciences Centre | 2010-12-01 |
| A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) (NCT01235962) | Novartis Pharmaceuticals | 2010-11-30 |
| Multi-Tracer PET Assessment of Primary Brain Tumors (NCT00813566) | University of Utah | 2010-11-12 |
| A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors (NCT01231594) | Novartis Pharmaceuticals | 2010-11-05 |
| GSK1120212 Rollover Study (NCT01376310) | Novartis Pharmaceuticals | 2010-11-02 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| Caris Biorepository Research Protocol (NCT01499394) | Caris Science, Inc. | 2010-11-01 |
| Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma (NCT01328106) | GlaxoSmithKline | 2010-11-01 |
| Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient (NCT01213160) | AstraZeneca | 2010-11-01 |
| Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases (NCT01248429) | Centre Oscar Lambret | 2010-11-01 |
| A Study of LY2584702 in Solid Tumors (NCT01241461) | Eli Lilly and Company | 2010-11-01 |
| An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor (NCT01231568) | GlaxoSmithKline | 2010-10-21 |
| Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients (NCT01207206) | Tel-Aviv Sourasky Medical Center | 2010-10-01 |
| Development of a Biomarker for Dietary Furanocoumarins (NCT01142037) | University of Minnesota | 2010-10-01 |
| Promotora-based Latino Family CVD Risk Reduction (NCT01714271) | University of California, Los Angeles | 2010-10-01 |
| Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors (NCT01188499) | TetraLogic Pharmaceuticals | 2010-10-01 |
| Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors (NCT02629926) | The Leeds Teaching Hospitals NHS Trust | 2010-10-01 |
| Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders (NCT04208243) | University of Colorado, Denver | 2010-09-29 |
| Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel (NCT01192165) | GlaxoSmithKline | 2010-09-14 |
| Study of the Prevention of Anal Cancer (NCT02007421) | Kirby Institute | 2010-09-10 |
| Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) (NCT01136005) | Impaqtt Foundation | 2010-09-01 |
| Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV (NCT01205581) | St. Jude Children's Research Hospital | 2010-09-01 |
| Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients? (NCT01049672) | Gloucestershire Hospitals NHS Foundation Trust | 2010-09-01 |
| Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers (NCT01149434) | University of Utah | 2010-09-01 |
| VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK (NCT01205230) | GlaxoSmithKline | 2010-09-01 |
| Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir (NCT01173913) | The Netherlands Cancer Institute | 2010-09-01 |
| An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States (NCT01211990) | National Institute of Mental Health (NIMH) | 2010-08-31 |
| Hypofractionated Stereotactic Boost in Prostate Cancer (NCT01596816) | Centre Oscar Lambret | 2010-08-31 |
| Social Contextual Influences on Physical Activity (NCT01195337) | M.D. Anderson Cancer Center | 2010-08-16 |
| Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (NCT02158637) | Mayo Clinic | 2010-08-01 |
| Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer (NCT01231581) | GlaxoSmithKline | 2010-08-01 |
| Exercise Information for Women With Cancer (NCT03120819) | Oregon Health and Science University | 2010-08-01 |
| A Study of PNT2258 in Patients With Advanced Solid Tumors (NCT01191775) | Sierra Oncology LLC - a GSK company | 2010-08-01 |
| Safety & Health Improvement: Enhancing Law Enforcement Departments (NCT01279941) | Oregon Health and Science University | 2010-08-01 |
| St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level (NCT01185093) | St. Jude Children's Research Hospital | 2010-08-01 |